ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

NCAB To Seek Changes In Cancer Act Renewal, Budget Improvements

November 20, 1987

In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut

February 22, 1980

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994